Skip to main content

Table 1 Laboratory findings of the patient on admission

From: A rare case of ectopic ACTH syndrome with rhabdomyolysis

Parameter

Patient’s value

Reference range

Blood routine

  WBC

11.19

3.5–9.5 × 109/L

  Neut%

10.53

1.8–6.3 × 109/L

  Hb

151

130–175 g/L

  PLT

149

125–350 × 109/L

Urine routine

  pH

7.5

5.5-8.0

  Glu

-

-

  Ket

-

-

Liver function

  ALT

52

9–50 U/L

  AST

96

15–40 U/L

  GGT

25

10–60 U/L

  ALP

77

45–125 U/L

  TBil

13.3

3.4–17.1 µmol/L

  DBil

3.9

0-3.4 µmol/L

  TP

50.5

65–85 g/L

  ALB

30.6

40–55 g/L

Renal function

  BUN

5.91

3.9–9.5 mmol/L

  Cr

64

57–111 µmol/L

  UA

289

208–428 µmol/L

  eGFR

99.27

> 90 mL/min/1.73m2

Blood gas analysis

  PH

7.58

7.35–7.45

  PCO2

51

35–45 mmHg

  PO2

63

80–100 mmHg

  SB

40.8

22–27 mmol/L

  BE

20.5

-3-+3 mmol/L

  HCO3-

46.7

22–27 mmol/L

Electrolyte

  Urine potassium*

155.7

25–100 mmol/24 h

  Synchronizing serum potassium

2.49

3.5–5.3 mmol/L

  Urine sodium

296.4

130.0-260.0 mmol/24 h

  Synchronizing serum sodium

142

137–147 mmol/L

  Urine calcium

9.35

25.0–38.0 mmol/24 h

  Synchronizing serum calcium

1.83

2.11–2.52 mmol/L

  Calibration of serum calcium#

2.02

2.11–2.52 mmol/L

  Urine phosphorus

24.68

32.3–38.4 mmol/24 h

  Synchronizing serum phosphorus

0.74

0.85–1.51 mmol/L

  FPG

7.4

3.9–6.1 mmol/L

  HbA1c

5.7

4–6 %

OGTT

  Glucose-0 min

7.82

3.9–6.1 mmol/L

  Glucose − 30 min

8.79

 

  Glucose − 60 min

9.41

 

  Glucose-120 min

7.95

< 7.8 mmol/L

  Glucose − 180 min

6.94

 

  Insulin-0 min

151.5

5.0–25 mIU/L

  Insulin-30 min

186.5

 

  Insulin-60 min

136.2

 

  Insulin-120 min

145.8

 

  Insulin-180 min

174.1

 

 Lipid

  CHO

3.57

3.1–5.69 mmol/L

  TG

1.09

0.56–1.47 mmol/L

  LDL

1.89

2.07–3.10 mmol/L

Coagulation function

  PTA

84 %

84-128 %

  PT

14.6

11–14 s

  TT

17.8

14–21 s

  APTT

31.5

28-43.5 s

  INR

1.11

0.94–1.3

  FIB

2.08

2–4 g/L

  FDP

0.98

0–5 mg/L

  D-D

0.77

0–1.0 mg/L

  Mb

741.3

0-146.9 ng/mL

  TnT

0.067

0-0.014 ng/mL

Myocardial enzyme

  CK

695

50–310 U/L

  CKMB

73

0–24 U/L

  Pro-BNP

182.6

0-125 pg/mL

  PCT

1.45

< 0.5 ng/mL

Tumour biomarkers

  CEA

4.930

0.00-3.40 g/mL

  NSE

52.36

0.00-16.30 ng/mL

  CYFRA21-1

8.750

0.00-3.30 ng/mL

  CA19-9

44.11

0–39 U/mL

  SCCA

0.77

< 1.5 ng/mL

  Free-PSA

0.474

0–4 ng/mL

  AFP

5.83

0–7 ng/mL

  CA125

21.4

0–35 U/mL

  CA72-4

1.6

0-9.8 U/mL

  1. WBC white blood cell count, Neut% percentage of neutrophils, Hb haemoglobin, PLT platelet, Glu glucose, Ket ketone, ALT alanine aminotransferase, AST aspartate aminotransferase, GGT glutamyltranspeptidase, TBil total bilirubin, DBil direct bilirubin, TP total protein, ALB albumin, BUN blood urea nitrogen, Cr creatinine, UA uric acid, eGFR estimated glomerular filtration ratio, FPG fasting plasma glucose, HbA1c glycosylated haemoglobin, OGTT oral glucose tolerance test, CHO cholesterol, TG triglyceride, LDL low-density lipoprotein cholesterol, PCO2 partial pressure of carbon dioxide, PO2 partial pressure of oxygen, SB standard bicarbonate, BE base excess, HCO3- bicarbonate, Mb myoglobin, TnT troponin T, pro-BNP pro-brain natriuretic peptide, PCT procalcitonin, CK creatine kinase, CKMB creatine kinase isoenzyme, PTA prothrombin time activity, PT prothrombin time, TT thrombin time, APTT activated partial thrombin time, INR international normalized ratio, FIB fibrinogen, FDP fibrin degradation product, D-D D dimer, CEA carcinoembryonic antigen, NSE neuron-specific enolase, CYFRA21-1 cytokeratin 21 − 1 fragment, CA19-9 carbohydrate antigen 19 − 9, SCCA squamous cell carcinoma antigen, PSA prostate specific antigen, AFP alpha foetal protein, CA125 carbohydrate antigen 125, CA72-4 carbohydrate antigen 72 − 4. *, the criteria of inappropriate increased urinary potassium excretion are urine potassium >25mmol/24h when serum potassium <3.5mmol/L or urine potassium >20mmol/24h when serum potassium <3.0mmol/L. #, Calciumcalibrated =Calciummeasured+(40-serum albumin) ×0.02